Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BSX

Boston Scientific Corp

Feb 06 • 04:00PM ET

76.27

-1.37 -1.76 %

Healthcare • Medical Devices • USA • NYSE

Feb 06, 8:15 AMStifel cuts its price target on Boston Scientific to $110 from $125 while reiterating a Buy rating following the company’s recent quarterly report.

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO VUG IVV SPY XLV VHT IHI MGK SPYM

Scroll to Statements

Index	S&P 500	P/E	39.33	EPS (ttm)	1.94	Insider Own	0.38%	Shs Outstand	1.48B	Perf Week	-18.45%
Market Cap	113.11B	Forward P/E	19.42	EPS next Y	3.93	Insider Trans	-5.91%	Shs Float	1.48B	Perf Month	-22.69%
Enterprise Value	124.02B	PEG	1.46	EPS next Q	0.79	Inst Own	94.06%	Short Float	1.58%	Perf Quarter	-22.88%
Income	2.90B	P/S	5.63	EPS this Y	13.24%	Inst Trans	0.36%	Short Ratio	1.94	Perf Half Y	-25.92%
Sales	20.07B	P/B	4.83	EPS next Y	13.36%	ROA	6.91%	Short Interest	23.42M	Perf YTD	-20.01%
Book/sh	15.78	P/C	82.38	EPS next 5Y	13.34%	ROE	12.66%	52W High	109.50 -30.35%	Perf Year	-27.34%
Cash/sh	0.93	P/FCF	29.58	EPS past 3/5Y	63.25% -	ROIC	8.29%	52W Low	74.86 1.88%	Perf 3Y	60.43%
Dividend Est.	-	EV/EBITDA	25.84	Sales past 3/5Y	16.54% 15.16%	Gross Margin	70.32%	Volatility	4.95% 3.08%	Perf 5Y	112.16%
Dividend TTM	-	EV/Sales	6.18	EPS Y/Y TTM	55.39%	Oper. Margin	19.43%	ATR (14)	3.35	Perf 10Y	335.08%
Dividend Ex-Date	-	Quick Ratio	0.96	Sales Y/Y TTM	19.88%	Profit Margin	14.44%	RSI (14)	24.14	Recom	1.22
Dividend Gr. 3/5Y	- -	Current Ratio	1.51	EPS Q/Q	18.30%	SMA20	-15.53%	Beta	0.70	Target Price	105.37
Payout	0.00%	Debt/Eq	0.51	Sales Q/Q	15.90%	SMA50	-18.78%	Rel Volume	2.68	Prev Close	77.64
Employees	53000	LT Debt/Eq	0.49	Earnings	Feb 04 BMO	SMA200	-23.90%	Avg Volume	12.06M	Price	76.27
IPO	May 19, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.49% 0.12%	Trades		Volume	32,296,591	Change	-1.76%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform	$125
Jun-16-25	Initiated	Leerink Partners	Outperform	$118
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55

Show Previous Ratings

Feb-06-26 09:31AM	Haemonetics Q3 Earnings & Revenues Beat, Margins Up, Stock Slips (Zacks)
08:15AM	The TAVR Pioneer Bets Everything on One Market as Its Competitor Spreads Risk (24/7 Wall St.)
08:08AM	Boston Scientific price target lowered to $110 from $125 at Stifel (TipRanks)
Feb-05-26 12:33PM	DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features (Zacks)
10:27AM	CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains (Zacks)
09:45AM	Loading…
09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
09:25AM	STE Q3 Earnings Meet, Revenues Beat, Stock Dips in Aftermarket Trading (Zacks)
09:00AM	Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results (TipRanks)
08:23AM	Boston Scientifics shares tumble 18% despite strong FY25 growth (Medical Device Network)
05:44AM	J.P. Morgan Healthcare Conference 2026 Report (Pharmaceutical Technology)
12:34AM	BSX Q4 Deep Dive: Growth Engines Face Scrutiny as Market Reacts to Guidance and Segment Dynamics (StockStory)
12:07AM	Boston Scientific Q4 Earnings Call Highlights (MarketBeat)
Feb-04-26 05:41PM	Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors (Motley Fool) -17.59%
04:41PM	These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More (Barrons.com)
04:09PM	Boston Scientific Hits An 18-Month Low On A 'Sore Spot' For Its Most Hyped Device (Investor's Business Daily)
02:03PM	Loading…
02:03PM	Boston Scientific Corp (BSX) Q4 2025 Earnings Call Highlights: Surpassing Financial Goals with ... (GuruFocus.com)
01:56PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
01:21PM	Why Boston Scientific Stock Plummeted Today (Motley Fool)
01:20PM	Software Stocks Plummet, Bitcoin Erases Post-Trump Election Rally: What's Moving Markets Wednesday? (Benzinga)
01:16PM	Boston Scientific (BSX) Earnings Transcript (Motley Fool)
12:57PM	Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test (Zacks)
12:47PM	Stock Market Today: Dow Rises, Nasdaq Sinks Amid Tech Sell-Off; This Medical Stock Tumbles (Live Coverage) (Investor's Business Daily)
12:25PM	Why Boston Scientific (BSX) Shares Are Getting Obliterated Today (StockStory)
12:15PM	BSX Stock Dips in Premarket Trading Despite Q4 Earnings, Revenue Beat (Zacks)
11:59AM	Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves (Zacks)
11:55AM	Reasons to Hold Veeva Systems Stock in Your Portfolio for Now (Zacks)
11:03AM	GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls (Zacks)
10:42AM	Texas Instruments to buy Silicon Labs, Enphase stock surges 40% (Yahoo Finance Video)
10:32AM	AMD Earnings Beat Expectations. Why Its One of the S&P 500s Worst Stocks Today. (Barrons.com)
10:30AM	Boston Scientific Earnings Beat Estimates. Its the Worst Stock in the S&P 500 Today. (Barrons.com)
10:03AM	Loading…
10:03AM	Boston Scientific Stock Hits 52-Week Low On Soft 2026 Outlook (Benzinga)
09:34AM	TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up (Zacks)
09:30AM	Boston Scientific (BSX) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
09:19AM	Boston Scientific Profit, Sales Rise but Issues Soft Guidance (The Wall Street Journal)
08:12AM	Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. (Barrons.com)
08:02AM	Boston Scientific shares slide on cautious 2026 revenue forecast (Reuters)
07:40AM	Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:41AM	Boston Scientific: Q4 Earnings Snapshot (Associated Press Finance)
06:40AM	Boston Scientific (NYSE:BSX) Reports Q4 CY2025 In Line With Expectations (StockStory)
06:30AM	Boston Scientific announces results for fourth quarter and full year 2025 (PR Newswire)
05:24AM	Uber and Alphabet headline earnings slate (MarketWatch)
04:36AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
04:24AM	Stock Market Today: Dow, S&P 500 and Nasdaq consolidate after software rout; AMD results weigh; Alphabet earnings on tap; gold recovers $5,000 level. (MarketWatch)
Feb-03-26 01:13PM	GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut (Zacks)
12:02PM	Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions (Zacks)
11:18AM	Silver Economy Boom: Investing in Healthcare's Aging Tailwinds (Zacks)
10:29AM	Natera Files Signatera CDx PMA With FDA for Bladder Cancer MRD Test (Zacks)
10:23AM	DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand (Zacks)
08:29AM	MedTech Stocks to Watch for Earnings on Feb. 4: BSX, ALGN & More (Zacks)
05:37AM	4 Medical Product Stocks to Watch From a Challenging Industry (Revised) (Zacks)
03:01AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-02-26 10:03PM	Earnings To Watch: Boston Scientific (BSX) Reports Q4 Results Tomorrow (StockStory)
06:02PM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
09:51AM	Here's Why You Should Add Inogen Stock to Your Portfolio Now (Zacks)
09:49AM	Revvity Stock Up as Q4 Earnings Beat, Revenues In Line With Estimates (Zacks)
09:08AM	4 Medical Product Stocks to Watch From a Challenging Industry (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
02:13AM	Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-01-26 11:13PM	Deal fever returns: 2026 looks hot for M&A (TheStreet)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
Jan-30-26 04:57PM	Jobs Report, More Tech Earnings: What to Watch Next Week (The Wall Street Journal)
02:31PM	Boston Scientific (BSX) Garnering Bullish Views Amid Penumbra Acquisition (Insider Monkey)
01:34PM	GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test (Zacks)
12:07PM	SENS Stock Up as Eversense 365 CGM Wins European CE Mark Approval (Zacks)
10:25AM	SYK Stock Gains as Q4 Earnings & Sales Beat on Strong Mako Adoption (Zacks)
09:15AM	Boston Scientific (BSX) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Jan-29-26 01:32PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
01:28PM	Organon Completes Divesture of JADA System to Laborie Medical (Zacks)
12:47PM	Reasons to Add AngioDynamics Stock to Your Portfolio for Now (Zacks)
12:17PM	CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up (Zacks)
08:48AM	Thermo Fisher's Q4 Earnings & Revenues Top Estimates, Stock Climbs (Zacks)
08:32AM	Here's Why You Should Retain Glaukos Stock in Your Portfolio Now (Zacks)
01:38AM	Boston Scientific Stock: Analyst Estimates & Ratings (Barchart)
Jan-28-26 12:35PM	Here's Why You Should Retain Ecolab Stock in Your Portfolio Now (Zacks)
12:31PM	OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System (Zacks)
11:26AM	QT Imaging & Olea Medical Partner to Enhance Cloud Imaging Platform (Zacks)
09:04AM	Boston Scientific Corporation (BSX): A Bull Case Theory (Insider Monkey)
08:24AM	Reasons to Retain Baxter International Stock in Your Portfolio Now (Zacks)
07:27AM	Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings? (Zacks)
Jan-27-26 12:07PM	ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures (Zacks)
11:47AM	BDX Introduces BD Research Cloud 7.0 for Advanced Flow Cytometry (Zacks)
07:53AM	CLPT Gets EU MDR Certification for ClearPoint Navigation Software (Zacks)
Jan-26-26 03:09PM	Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage (CNBC TV)
11:40AM	PAHC vs. BSX: Which Stock Is the Better Value Option? (Zacks)
07:24AM	Boston Scientific touts long-term data of SCS therapy (Medical Device Network)
05:39AM	Medtronic wins CE mark for single-shot pulsed field ablation catheter (MedTech Dive)
05:06AM	Intuitives cardiac initiative includes valve repair, LAA closure (MedTech Dive)
Jan-24-26 01:18AM	Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. (Barrons.com)
Jan-23-26 10:58PM	Oppenheimer Questions Valuation of Boston Scientific's $14.5 Billion Penumbra Deal (Insider Monkey)
06:00PM	Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider (Zacks)
11:43AM	ISRG Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
Jan-22-26 09:52PM	Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific's (BSX) Mew Market Dominance (Insider Monkey)
12:32PM	Here's Why You Should Retain INSP Stock in Your Portfolio for Now (Zacks)
Jan-21-26 07:07PM	J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll (Investor's Business Daily)
12:30PM	Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface (Benzinga)
10:49AM	CAPR Updates FDA on Deramiocel BLA, Plans HOPE-3 CSR Filing in February (Zacks)
08:01AM	Here's Why You Should Hold Bio-Rad Stock in Your Portfolio Now (Zacks)
07:58AM	Here's Why You Should Retain Revvity Stock in Your Portfolio for Now (Zacks)
07:54AM	Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? (Zacks)
Jan-20-26 01:39PM	Intuitive Surgical Pre-Q4 Analysis: Buy, Hold or Sell ISRG Stock Now? (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mahoney Michael F	Chairman, President & CEO	Feb 02 '26	Option Exercise	25.78	95,754	2,468,482	1,572,636	Feb 03 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Feb 02 '26	Sale	93.49	160,901	15,043,394	1,411,735	Feb 03 04:12 PM
MICHAEL F MAHONEY	Officer	Feb 02 '26	Proposed Sale	93.49	160,901	15,043,390		Feb 02 04:12 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Option Exercise	24.81	17,313	429,491	40,913	Dec 02 05:04 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Dec 01 '25	Sale	101.55	17,313	1,758,189	23,600	Dec 02 05:04 PM
ARTHUR C BUTCHER	Officer	Dec 01 '25	Proposed Sale	101.55	17,313	1,758,188		Dec 01 04:02 PM
Zane Ellen M	Director	Nov 06 '25	Sale	98.28	12,891	1,266,978	24,134	Nov 06 04:34 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Nov 04 04:15 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Nov 03 '25	Sale	99.47	50,000	4,973,338	178,342	Nov 04 04:15 PM
JOSEPH M FITZGERALD	Officer	Nov 03 '25	Proposed Sale	99.47	50,000	4,973,335		Nov 03 04:05 PM
Zane Ellen M	Director	Oct 27 '25	Sale	101.13	9,990	1,010,301	27,035	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Sale	102.24	2,901	296,599	24,134	Oct 28 05:44 PM
Zane Ellen M	Director	Oct 28 '25	Proposed Sale	102.24	2,901	296,592		Oct 28 10:55 AM
Zane Ellen M	Director	Oct 27 '25	Proposed Sale	100.91	9,990	1,008,081		Oct 27 10:50 AM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Oct 01 04:22 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Oct 01 '25	Sale	98.47	50,000	4,923,327	178,342	Oct 01 04:22 PM
JOSEPH M FITZGERALD	Officer	Oct 01 '25	Proposed Sale	98.47	50,000	4,923,325		Oct 01 04:04 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Sep 03 04:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 02 '25	Sale	105.43	50,000	5,271,416	178,342	Sep 03 04:17 PM
JOSEPH M FITZGERALD	Officer	Sep 02 '25	Proposed Sale	105.43	50,000	5,271,415		Sep 02 04:08 PM
Monson Jonathan	EVP and CFO	Aug 02 '25	Option Exercise	0.00	1,090	0	35,817	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Aug 04 05:43 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Aug 01 '25	Sale	104.63	50,000	5,231,670	178,342	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Option Exercise	24.81	17,313	429,493	40,913	Aug 04 05:43 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 01 '25	Sale	104.63	17,313	1,811,520	23,600	Aug 04 05:43 PM
ARTHUR C BUTCHER	Officer	Aug 01 '25	Proposed Sale	104.63	17,313	1,811,519		Aug 01 04:03 PM
JOSEPH M FITZGERALD	Officer	Aug 01 '25	Proposed Sale	104.63	50,000	5,231,665		Aug 01 04:02 PM
FUJIMORI YOSHIAKI	Director	Jul 29 '25	Sale	106.99	2,901	310,378	2,081	Jul 30 04:06 PM
YOSHIAKI FUJIMORI	Director	Jul 29 '25	Proposed Sale	106.99	2,901	310,378		Jul 29 07:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Sale	106.03	4,000	424,120	18,479	Jul 28 04:10 PM
LUDWIG EDWARD J	Director	Jul 25 '25	Proposed Sale	107.46	4,000	429,840		Jul 25 01:02 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Option Exercise	26.15	50,000	1,307,500	228,342	Jul 02 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jul 01 '25	Sale	106.97	50,000	5,348,315	178,342	Jul 02 04:09 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01 '25	Option Exercise	0.00	4,036	0	35,403	Jul 02 04:09 PM
JOSEPH M FITZGERALD	Officer	Jul 01 '25	Proposed Sale	106.97	50,000	5,348,310		Jul 01 04:09 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Option Exercise	26.15	56,372	1,474,128	234,714	Jun 04 07:44 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jun 04 '25	Sale	102.88	56,372	5,799,630	178,342	Jun 04 07:44 PM
JOSEPH M FITZGERALD	Officer	Jun 04 '25	Proposed Sale	102.88	56,372	5,799,625		Jun 04 04:02 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Option Exercise	20.67	105,619	2,183,161	1,641,325	Jun 03 04:47 PM
Mahoney Michael F	Chairman, President & CEO	Jun 02 '25	Sale	103.69	164,443	17,051,136	1,476,882	Jun 03 04:47 PM
MICHAEL F MAHONEY	Officer	Jun 02 '25	Proposed Sale	103.69	164,443	17,051,132		Jun 02 04:05 PM
LUDWIG EDWARD J	Director	May 29 '25	Sale	104.59	4,000	418,368	22,479	May 30 04:08 PM
LUDWIG EDWARD J	Director	May 29 '25	Proposed Sale	104.54	4,000	418,160		May 29 03:39 PM
Brown Vance R	SVP, GC and Corp. Secretary	May 21 '25	Sale	106.42	4,826	513,583	31,367	May 22 04:08 PM
VANCE BROWN	Officer	May 21 '25	Proposed Sale	106.42	4,826	513,583		May 21 04:09 PM
Sorenson John Bradley	EVP, Global Operations	May 02 '25	Option Exercise	0.00	4,204	0	25,195	May 06 04:37 PM
Sorenson John Bradley	EVP, Global Operations	May 05 '25	Sale	104.54	4,572	477,957	18,705	May 06 04:37 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02 '25	Option Exercise	0.00	2,102	0	24,337	May 06 04:36 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Option Exercise	20.67	105,619	2,183,161	1,700,149	May 05 05:16 PM
Mahoney Michael F	Chairman, President & CEO	May 01 '25	Sale	102.48	164,443	16,851,974	1,535,706	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Option Exercise	24.81	17,314	429,515	39,549	May 05 05:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 01 '25	Sale	102.06	17,314	1,766,982	22,235	May 05 05:16 PM
JOHN B SORENSON	Officer	May 05 '25	Proposed Sale	104.54	4,572	477,957		May 05 04:04 PM
MICHAEL F MAHONEY	Officer	May 01 '25	Proposed Sale	102.48	164,443	16,851,966		May 01 04:05 PM
ARTHUR C BUTCHER	Officer	May 01 '25	Proposed Sale	102.06	17,314	1,766,981		May 01 04:01 PM
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience